J1574 – Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1574
- Long description
- Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
- Short description
- Inj, ganciclovir (exela)
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 2023
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J1574?
J1574 is a HCPCS Level II code for injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg.
Does Medicare cover J1574?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1562 – Injection, immune globulin (vivaglobin), 100 mg
- J1566 – Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1568 – Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569 – Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570 – Injection, ganciclovir sodium, 500 mg
- J1571 – Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572 – Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573 – Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
- J1575 – Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
- J1576 – Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1577 – Injection, immune globulin (qivigy), 100 mg
- J1580 – Injection, garamycin, gentamicin, up to 80 mg
- J1590 – Injection, gatifloxacin, 10 mg
- J1595 – Injection, glatiramer acetate, 20 mg
- J1596 – Injection, glycopyrrolate, 0.1 mg
- J1597 – Injection, glycopyrrolate (glyrx-pf), 0.1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.